
Halma plc, a company established in 1894 and headquartered in Amersham, United Kingdom, specializes in delivering innovative technological solutions across critical safety, health, and environmental sectors. Its operations are organized into three distinct divisions: Safety, Environmental & Analysis, and Medical. The Safety division offers a range of protective technologies, encompassing fire detection and advanced suppression systems, safety mechanisms for elevators, security sensors, and systems for managing pedestrian and vehicle movement. It also develops specialized interlocks for secure process control, as well as solutions for explosion prevention and corrosion oversight. These offerings cater to various applications, including elevator safety, fire management, crowd and traffic flow, industrial access, and secure storage solutions. Focused on monitoring and analysis, the Environmental & Analysis segment provides advanced optical, optoelectronic, and spectral imaging solutions. It also develops instruments for tracking water, air, and gas quality, including devices to detect hazardous gases and assess overall air purity, alongside comprehensive water analysis and treatment systems. Its expertise serves fields such as optical diagnostics, water management, gas detection, and broad environmental monitoring. The Medical division is dedicated to healthcare innovations, supplying essential fluidic components for medical diagnostics and original equipment manufacturers. It also produces laboratory instruments and platforms designed to provide crucial insights into patient health, aiding providers in clinical decision-making. Furthermore, the segment develops specialized technologies and approaches to facilitate in-vitro diagnostics, scientific discoveries, and product development in life sciences, ensuring beneficial outcomes across diverse medical specialties.
Halma plc trades as HLMA.L on LSE. The company is classified in Industrials / Conglomerates and reports in GBP.
The current profile places the business in Conglomerates. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows £2.25B of revenue and £296.40M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Halma plc can be compared against peers such as Amcomri Group plc, Babcock International Group PLC, Diploma PLC, International Consolidated Airlines Group S.A., Intertek Group plc, Melrose Industries PLC.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £17.87B, beta of 0.97, and return on equity of +15.6%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
HLMA.L currently shows total debt of £849.00M and beta of 0.97. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.halma.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.